Noble Life Sciences Inc

Preclinical CRO-in vitro and in vivo testing services for cell and gene therapy, biologics, vaccines, drugs, and devices

Founded 2010

United States 38 employees Seed Total: $340.00K Biotechnology, Life Sciences +1

Noble Life Sciences Inc is a biotechnology startup based in United States, specializing in preclinical contract research organization (CRO) services. Founded in 2010, the company offers in vitro and in vivo testing services for cell and gene therapy, biologics, vaccines, drugs, and devices. With a focus on accelerating product development from concept to clinic, Noble's state-of-the-art facilities in Sykesville, MD, situated in the BioHealth Capital Region, provide a full continuum of preclinical drug, vaccine, and medical device development services. The company's integrated in vitro and in vivo services cover cellular and animal disease model development, experimental design, efficacy, toxicity, biodistribution, and product release studies in small and large animals. Moreover, Noble excels in custom antibody production services, as well as tissue and animal sourcing. Notably, the company's vivarium services group offers comprehensive support for in vivo R&D, including custom housing, husbandry, breeding, facility and program management, and high-level implementation of preclinical drug development services. Noble Life Sciences Inc's deep expertise and years of experience are its key advantages, ensuring the optimization and acceleration of preclinical studies for its clients. The company's $100.00K Seed Round investment at 15 January 2014, led by TEDCO, underscores confidence in its potential to drive innovation in the biotechnology and pharmaceutical industries. With a strong emphasis on quality and scientific foundation, Noble Life Sciences is poised to make significant contributions to the advancement of preclinical research and development.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed	$100.00K	1	TEDCO	01 Jan 2014
Seed	$240.00K	-		01 Dec 2010

Funding Stage

Amount

Investors

Lead Investors

Date

Seed

$100.00K

TEDCO

01 Jan 2014

Seed

$240.00K

01 Dec 2010

FAQ About Noble Life Sciences Inc

Preclinical CRO-in vitro and in vivo testing services for cell and gene therapy, biologics, vaccines, drugs, and devices

Noble Life Sciences Inc was founded in 2010.

Noble Life Sciences Inc is headquartered in United States.

Noble Life Sciences Inc operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Preclinical CRO, In vitro testing, In vivo testing and Cell therapy.

Noble Life Sciences Inc has approximately 38 employees.

Noble Life Sciences Inc has completed 2 funding rounds, raising a total of $340.00K. The latest funding stage is Seed.

Top alternatives and competitors to Noble Life Sciences Inc include Pharmatest Services, Newcells Biotech (Axol Bioscience), PhenoVista, Alpha Genesis Inc., Emulate, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Noble Life Sciences Inc and Pharmatest Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Noble Life Sciences Inc

Funding Rounds & Investors (2)

Noble Life Sciences Inc Alternatives & Competitors

FAQ About Noble Life Sciences Inc